• Explore /
  • Poster
  • / Final results of phase II study of S-1, oral leucovorin, oxaliplatin, and bevacizumab combination therapy (SOL+BV; SOLA) in metastatic colorectal cancer (mCRC).

Final results of phase II study of S-1, oral leucovorin, oxaliplatin, and bevacizumab combination therapy (SOL+BV; SOLA) in metastatic colorectal cancer (mCRC).

Abstract Poster

Authors

null

Kentaro Yamazaki

Shizuoka Cancer Center, Shizuoka, Japan

Kentaro Yamazaki , Tomohiro Nishina , Takeshi Kato , Takayuki Yoshino , Yoshinori Miyata , Taito Esaki , Toshikazu Moriwaki , Narikazu Boku , Ichinosuke Hyodo

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2014 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

General Poster Session C: Cancers of the Colon and Rectum

Track

Cancers of the Colon, Rectum, and Anus

Sub Track

Multidisciplinary Treatment

Clinical Trial Registration Number

090881

Citation

J Clin Oncol 32, 2014 (suppl 3; abstr 574)

DOI

10.1200/jco.2014.32.3_suppl.574

Abstract #

574

Poster Bd #

D23

Abstract Disclosures

Similar Posters

First Author: Manabu Kurayoshi

First Author: Jean-Louis Legoux

First Author: Hiroyuki Uetake

First Author: Kazuhiro Ezaka